The inflammasome: more than a protective innate immune mechanism by Stoilova, B, Vyas, P

Mechanisms of response and resistance to AML therapies by Stoilova, B, Moore, R, Metzner, M, Zheng, Z, Konopleva, M, DiNardo, C, Vyas, P

Impact of mutant haemopoietic transcription factor GATA1s on haemopoiesis by Vyas, P, Juban, G, Sakakini, N, Soady, K, Chagraoui, H, Stoilova, B, Garnett, C, Lhermitte, L, Karkoulia, E, Strouboulis, J, Porcher, C, Roberts, I

Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved by Aksöz, M, Gafencu, G-A, Stoilova, B, Buono, M, Zhang, Y, Turkalj, S, Meng, Y, Jakobsen, NA, Metzner, M, Clark, S-A, Beveridge, R, Thongjuea, S, Vyas, P, Nerlov, C

C/EBPα and GATA-2 mutations induce bilineage acute erythroid leukemia through transformation of a neomorphic neutrophil-erythroid progenitor by Di Genua, C, Valletta, S, Buono, M, Stoilova, B, Sweeney, C, Rodriguez-Meira, A, Grover, A, Meng, Y, Beveridge, R, Aboukhalil, Z, Karamitros, D, Belderbos, ME, Bystykh, L, Thongjuea, S, Vyas, P, Nerlov, C

Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay by Juban, G, Nathalie Sakakini, Chagraoui, H, Cruz Hernandez, D, Cheng, Q, Soady, K, Stoilova, B, Garnett, C, Waithe, D, Otto, G, Doondeea, J, Usukhbayar, B, Karkoulia, E, Alexiou, M, Strouboulis, J, Morrissey, E, Roberts, I, Porcher, C, Vyas, P

A novel model of human hemopoiesis based on single cell functional and transcriptional analysis of lympho-myeloid progenitors by Stoilova, B, Karamitros, D, Aboukhalil, Z, Hamey, F, Reinisch, A, Samitsch, M, Quek, L, Otto, G, Repapi, E, Doondeea, J, Usukhbayar, B, Calvo, J, Taylor, S, Goardon, N, Six, E, Pflumio, F, Porcher, C, Majeti, R, Gottgens, B, Vyas, P

A phase Ib/II study of ivosidenib with venetoclax plus /- azacitidine in IDH1-mutated myeloid malignancies by Lachowiez, CA, Borthakur, G, Loghavi, S, Zeng, Z, Kadia, TM, Masarova, L, Takahashi, K, Tippett, GD, Smith, S, Garcia, JS, Bose, P, Jabbour, E, Ravandi, F, Daver, NG, Garcia-Manero, G, Stoilova, B, Vyas, P, Kantarjian, HM, Konopleva, M, Dinardo, CD

Single cell assays unveil functional and transcriptional heterogeneity of human hemopoietic lympho-myeloid progenitors by Stoilova, B, Karamitros, D, Aboukhalil, Z, Reinisch, A, Hamey, F, Samitsch, M, Quek, L, Otto, G, Repapi, E, Doondeea, J, Usukhbayar, B, Calvo, J, Taylor, S, Goardon, N, Six, E, Pflumio, F, Porcher, C, Majeti, R, Gottgens, B, Vyas, P

Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells. by Karamitros, D, Stoilova, B, Aboukhalil, Z, Hamey, F, Reinisch, A, Samitsch, M, Quek, L, Otto, G, Repapi, E, Doondeea, J, Usukhbayar, B, Calvo, J, Taylor, S, Goardon, N, Six, E, Pflumio, F, Porcher, C, Majeti, R, Göttgens, B, Vyas, P

A novel model of human lympho-myeloid progenitor hierarchy based on single cell functional and transcriptional analysis by Karamitros, D, Stoilova, B, Aboukhalil, Z, Reinisch, A, Hamey, F, Samitsch, M, Quek, L, Otto, G, Repapi, E, Doondeea, J, Usukhbayar, B, Calvo, J, Taylor, S, Goardon, N, Six, E, Pflumio, F, Porcher, C, Majeti, R, Gottgens, B, Vyas, P

Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia by Quek, L, David, M, Kennedy, A, Metzner, M, Amatangelo, M, Shih, A, Stoilova, B, Karamitros, D, Quivoron, C, Heiblig, M, Willekens, C, Saada, V, Peniket, A, Bernard, O, Agresta, S, Yen, K, Stein, E, De Botton, S, Thakurta, A, Levine, R, Penard-Lacronique, V, Vyas, P

Clonal heterogeneity of acute Myeloid Leukemia treated with the IDH2 inhibitor Enasidenib by Vyas, P, Quek, L, David, MD, Kennedy, A, Metzner, M, Amatangelo, M, Shih, A, Stoilova, B, Quivoron, C, Heiblig, M, Willekens, C, Saada, V, Alsafadi, S, Vijayabaskar, MS, Peniket, A, Bernard, OA, Agresta, S, Yen, K, MacBeth, K, Stein, E, Vassiliou, GS, Levine, R, De Botton, S, Thakurta, A, Penard-Lacronique, V

Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage. by Quek, L, Otto, G, Garnett, C, Lhermitte, L, Karamitros, D, Stoilova, B, Lau, I, Doondeea, J, Usukhbayar, B, Kennedy, A, Metzner, M, Goardon, N, Ivey, A, Allen, C, Gale, R, Davies, B, Sternberg, A, Killick, S, Hunter, H, Cahalin, P, Price, A, Carr, A, Griffiths, M, Virgo, P, Mackinnon, S, Grimwade, D, Freeman, S, Russell, N, Craddock, C, Mead, A, Peniket, A, Porcher, C, Vyas, P

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome by Labuhn, M, Perkins, K, Matzk, S, Varghese, L, Garnett, C, Papaemmanuil, E, Metzner, M, Kennedy, A, Amstislavskiy, V, Risch, T, Bhayadia, R, Samulowski, D, Hernandez, D, Stoilova, B, Iotchkova, V, Oppermann, U, Scheer, C, Yoshida, K, Schwarzer, A, Taub, J, Crispino, J, Weiss, M, Hayashi, A, Taga, T, Ito, E, Ogawa, S, Reinhardt, D, Yaspo, M, Campbell, P, Roberts, I, Constantinescu, S, Vyas, P, Heckl, D, Klusmann, J

A recurrent activating missense mutation in Waldenström macroglobulinemia affects the DNA binding of the ETS transcription factor SPI1 and enhances proliferation by Roos-Weil, D, Decaudin, C, Armand, M, Della-Valle, V, Diop, M, Ghamlouch, H, Ropars, V, Herate, C, Lara, D, Durot, E, Haddad, R, Mylonas, E, Damm, F, Pflumio, F, Stoilova, B, Metzner, M, Elemento, O, Dessen, P, Camara-Clayette, V, Cosset, F, Verhoeyen, E, Leblond, V, Ribrag, V, Cornillet-Lefebvre, P, Rameau, P, Azar, N, Charlotte, F, Morel, P, Charbonnier, J, Vyas, P, Mercher, T, Aoufouchi, S, Droin, N, Guillouf, C, Nguyen-Khac, F, Bernard, O